Protein particle-based vehicles for encapsulation and delivery of nutrients: Fabrication, digestion, and release properties

2021 ◽  
pp. 106963
Author(s):  
Cuihua Chang ◽  
Junhua Li ◽  
Yujie Su ◽  
Luping Gu ◽  
Yanjun Yang ◽  
...  
Keyword(s):  
2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Sandeep K. Gupta ◽  
Natalie A. Parlane ◽  
Dongwen Luo ◽  
Bernd H. A. Rehm ◽  
Axel Heiser ◽  
...  

AbstractMycobacterium avium subspecies paratuberculosis (MAP) causes chronic progressive granulomatous enteritis leading to diarrhoea, weight loss, and eventual death in ruminants. Commercially available vaccines provide only partial protection against MAP infection and can compromise the use of bovine tuberculosis diagnostic tests. Here, we report the development of a protein-particle-based vaccine containing MAP antigens Ag85A202–347-SOD1–72-Ag85B173–330-74F1–148+669–786 as a fusion (‘MAP fusion protein particle’). The fusion antigen displayed on protein particles was identified using mass spectrometry. Surface exposure and accessibility of the fusion antigen was confirmed by flow cytometry and ELISA. The MAP fusion protein particle vaccine induced strong antigen-specific T-cell immune responses in mice, as indicated by increased cytokine (IFN-γ and IL-17A) and costimulatory signals (CD40 and CD86) in these animals. Following MAP-challenge, a significant reduction in bacterial burden was observed in multiple organs of the mice vaccinated with the MAP fusion protein particle vaccine compared with the PBS group. The reduction in severity of MAP infection conferred by the MAP fusion protein particle vaccine was similar to that of Silirum and recombinant protein vaccines. Overall, the results provide evidence that MAP antigens can be engineered as a protein particulate vaccine capable of inducing immunity against MAP infection. This utility offers an attractive platform for production of low-cost particulate vaccines against other intracellular pathogens.


2013 ◽  
Vol 15 (4) ◽  
pp. 1200-1211 ◽  
Author(s):  
Sarah Zölls ◽  
Daniel Weinbuch ◽  
Michael Wiggenhorn ◽  
Gerhard Winter ◽  
Wolfgang Friess ◽  
...  

1997 ◽  
Vol 15 (12) ◽  
pp. 1280-1284 ◽  
Author(s):  
Sarah C. Gilbert ◽  
Magdalena Plebanski ◽  
Stephen J. Harris ◽  
Catherine E.M. Allsopp ◽  
Rebecca Thomas ◽  
...  
Keyword(s):  

Traffic ◽  
2018 ◽  
Vol 20 (1) ◽  
pp. 5-26 ◽  
Author(s):  
Michael Sacher ◽  
Nassim Shahrzad ◽  
Hiba Kamel ◽  
Miroslav P. Milev

1957 ◽  
Vol 55 (3) ◽  
pp. 402-413 ◽  
Author(s):  
N. M. Larin ◽  
Rachel Gaddum ◽  
W. G. Orbell

Quantitative studies have shown that the haemolytic activity of canine complement was in all essentials similar to guinea-pig complement. Canine serum which had been heated at 56° C. markedly enhanced the haemolytic activity of canine complement. The complement-enhancing power of heated canine serum was found to be increased with the concentration of serum up to 20%. Further concentration up to 50 % serum dilution, or the use of undiluted serum, resulted in a reduction of this effect.Serum aliquots were either pro-complementary or anti-complementary to cn, depending on whether they were heated at 56 or 62° C.Factors that possibly affect the complement-enhancement were investigated and evidence is presented which indicates that the electric charge on the protein particle is probably responsible for either the pro-complementary or anti-complementary serum activity; the mechanism of this, however, still remains obscure.The present work shows also that canine complement can be used instead of guinea-pig complement for testing canine sera with virus antigen by the complement-fixation reaction, an advantage of this being that the use of canine complement permits the testing of canine sera which are anti-complementary to guinea-pig complement.The data obtained are discussed in relation to canine complement and its specific activity.The authors are indebted to Professor W. I. B. Beveridge for his constructive advice, to Dr R. R. A. Coombs for his helpful comments on the complement activity, and to Dr Christine E. Rice of the Animal Diseases Research Institute, Canada, who has generously supplied the zymosan.Miss W. Barr and Miss M. Baker gave fine technical assistance throughout all the experiments. Miss M. Lambourne assisted in preparing the manuscript and graphs.


2019 ◽  
Vol 100 (2) ◽  
pp. 279-297 ◽  
Author(s):  
Monika Kalde ◽  
Liam Elliott ◽  
Raksha Ravikumar ◽  
Katarzyna Rybak ◽  
Melina Altmann ◽  
...  

Sensors ◽  
2008 ◽  
Vol 8 (10) ◽  
pp. 6225-6234 ◽  
Author(s):  
Yuriy Vashpanov ◽  
Jung Young Son ◽  
Kae Dal Kwack

Sign in / Sign up

Export Citation Format

Share Document